Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.
Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. have?
Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. published?
Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. has 2004 year in the ScholarIQ index.
What is the open-access status of Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.?
Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. has closed oa status in the ScholarIQ index.
What is the PMID of Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.?
The PMID for Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. is on the source record.
What is the OpenAlex record for Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.?
The OpenAlex for Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. is on the source record.